These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2741195

  • 1. Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.
    Killilea T, Coleman R, Ludden T, Peck CC, Rose D.
    Ther Drug Monit; 1989; 11(4):455-62. PubMed ID: 2741195
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a Bayesian regression-analysis computer program using non-steady-state phenytoin concentrations.
    Godley PJ, Ludden TM, Clementi WA, Godley SE, Ramsey RR.
    Clin Pharm; 1987 Aug; 6(8):634-9. PubMed ID: 3691009
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a Bayesian regression-analysis computer program for predicting phenytoin concentration.
    Ludden TM, Beal SL, Peck CC, Godley PJ.
    Clin Pharm; 1986 Jul; 5(7):580-5. PubMed ID: 3755661
    [Abstract] [Full Text] [Related]

  • 4. Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models.
    Pryka RD, Rodvold KA, Garrison M, Rotschafer JC.
    Ther Drug Monit; 1989 Jul; 11(4):450-4. PubMed ID: 2741194
    [Abstract] [Full Text] [Related]

  • 5. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
    Garrelts JC, Godley PJ, Horton MW, Karboski JA.
    Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D, Atanasova I, Dimitrova V, Robeva R, Unger S, Mück W.
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response.
    Lee C, Coleman RW, Mungall DR.
    Clin Pharm; 1987 May; 6(5):406-12. PubMed ID: 3665392
    [Abstract] [Full Text] [Related]

  • 12. Phenytoin cumulation profiles.
    Yuen GJ, Bell RD, Ludden TM.
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):355-68. PubMed ID: 6665297
    [Abstract] [Full Text] [Related]

  • 13. Individualizing phenytoin dosage regimens using a programmable calculator.
    Ng PK.
    Am J Hosp Pharm; 1980 Apr; 37(4):529-33. PubMed ID: 7377216
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Accuracy of three methods for predicting concentrations of free phenytoin.
    Beck DE, Farringer JA, Ravis WR, Robinson CA.
    Clin Pharm; 1987 Nov; 6(11):888-94. PubMed ID: 3677566
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nomogram for dosing warfarin at steady state.
    Fredriks DA, Coleman RW.
    Clin Pharm; 1991 Dec; 10(12):923-7. PubMed ID: 1773579
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.